Cargando…
Molecular Epidemiology of HCV Monoinfection and HIV/HCV Coinfection in Injection Drug Users in Liuzhou, Southern China
BACKGROUND: Hepatitis C virus (HCV) mono-infection and HCV/HIV (human immunodeficiency virus) co-infection are growing problems in injection drug users (IDU). Their prevalence and genotypic patterns vary with geographic locations. Access to harm reduction measures is opening up opportunities for imp...
Autores principales: | Tan, Yi, Wei, Qi Hou, Chen, Liu Jun, Chan, Pui Chung, Lai, Wen Sheng, He, Ming Liang, Kung, Hsiang Fu, Lee, Shui Shan |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2571986/ https://www.ncbi.nlm.nih.gov/pubmed/18974888 http://dx.doi.org/10.1371/journal.pone.0003608 |
Ejemplares similares
-
HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection
por: Grady, Bart P. X., et al.
Publicado: (2016) -
Liver Enzyme Alterations in HCV-Monoinfected and HCV/HIV-Coinfected Patients
por: Langohr, Klaus, et al.
Publicado: (2008) -
Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
por: Zuckerman, Autumn D., et al.
Publicado: (2019) -
Lower ribavirin biodisponibility in patients with HIV-HCV coinfection in comparison with HCV monoinfected patients
por: Hatu, Giorgiana, et al.
Publicado: (2014) -
Efficacy and tolerability of DAAs in HCV-monoinfected and HCV/HIV-coinfected patients with psychiatric disorders
por: de Gennaro, Nicolò, et al.
Publicado: (2020)